01/09/2026
Cancer survival in Ireland has improved significantly over the past two decades. That is something to be genuinely hopeful about.
New figures from the National Cancer Registry Ireland show that five-year survival across all invasive cancers has risen to 66%. For some cancers, survival is now around 95%.
But progress has not been equal.
Five-year survival is still just 15% for pancreatic cancer, 25% for liver, oesophageal and lung cancers, 32% for brain and spinal cord cancers, 37% for stomach cancer and 40% for ovarian cancer.
Six of these seven cancers still have five-year survival of 40% or less. Together, they account for around 44% of cancer deaths in Ireland.
This is why we focus our research funding where the unmet need remains greatest.
The new data also shows why that focus must go beyond earlier diagnosis alone. For pancreatic and liver cancer, five-year survival remains only 33% and 34% respectively even when diagnosed at stage I.
Earlier diagnosis matters enormously. So does new, better, kinder, smarter treatments and diagnostics which give people with cancer more options and more time with their loved ones.
The progress already made in cancer survival shows what research can achieve.
Our focus is on helping make sure that progress reaches more cancers, and more people, in the years ahead.
Read the full report here: https://www.ncri.ie/en/reports-publications/reports/cancer-in-ireland-1994-2023-annual-statistical-report-of-the-national